Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Silent ischemia--what should be done?]

H Gohlke1

  • 1Rehabilitationsklinik Sinnighofen, Bad Krozingen.

Schweizerische Medizinische Wochenschrift
|September 3, 1994
PubMed
Summary

Silent, undiagnosed, exercise-induced ischemia affects 0.5-3.5% of men aged 40-59. Treatment decisions for silent ischemia depend on risk factors and coronary artery disease extent.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The German CPU registry: Comparison of smokers and nonsmokers.

Herz·2018
Same author

Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures.

Scientific reports·2017
Same author

European guidelines on lifestyle changes for management of hypertension : Awareness and implementation of recommendations among German and European physicians.

Herz·2017
Same author

Chalcone-based Selective Inhibitors of a C4 Plant Key Enzyme as Novel Potential Herbicides.

Scientific reports·2016
Same author

[Cannabis--Position Paper of the German Respiratory Society (DGP)].

Pneumologie (Stuttgart, Germany)·2016
Same author

Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors.

Chemical communications (Cambridge, England)·2016

Area of Science:

  • Cardiology
  • Exercise Physiology

Context:

  • Silent, previously undiagnosed, exercise-induced ischemia affects 0.5-3.5% of men aged 40-59.
  • Prevalence is linked to coronary artery disease (CAD) rates within specific populations.
  • The underlying pathophysiological mechanism of silent ischemia is extracardiac.

Purpose:

  • To outline the prevalence, pathophysiology, and prognostic factors of silent ischemia.
  • To establish treatment criteria for silent ischemia based on risk stratification.
  • To emphasize the importance of managing cardiovascular risk factors.

Summary:

  • Silent ischemia diagnosis and treatment criteria mirror those for symptomatic ischemia and angina pectoris.
  • High-risk patients (low exercise threshold, severe ischemia, multi-vessel CAD, impaired left ventricular function) are candidates for invasive treatment.
  • Low-risk patients (high exercise threshold, minimal ischemia, single- or double-vessel disease) are managed medically.

Impact:

  • Informs clinical decision-making for diagnosing and managing silent ischemia.
  • Highlights the prognostic significance of functional impairment and CAD extent.
  • Underscores the critical role of comprehensive cardiovascular risk factor control for all patients.

Related Experiment Videos